Data / Form D filings / Liminatus Pharma, Inc.
Liminatus Pharma, Inc.: Form D filing
Liminatus Pharma, Inc., a pharmaceuticals company in Fullerton, CA, filed a Form D with the SEC in 2026. The latest, on June 18, 2026, reports $1.9 million sold of a $1.9 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2251 STERN GOODMAN STREET, SUITE E, Fullerton, CA, 92833
- Phone
- (213) 273-5453
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1971387
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | New notice | $1,861,920 | $1,861,920 | 1 | Jun 3, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Chris Kim | Executive Officer, Director | |
| Scott Dam | Executive Officer | |
| Byong C. Yoo | Executive Officer | |
| Sang-jin Daniel Lee | Executive Officer | |
| Beom K. Choi | Executive Officer | |
| Eun Sook Lee | Director | |
| Nicholas Fernandez | Director | |
| Ji Yeon Baek | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Jun 15, 2026 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Liminatus Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.